亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

甘草素 CAS:578-86-9

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 四川成都市付款后3天內(nèi)
品牌 鈉鈳鋰
過期 長(zhǎng)期有效
更新 2021-11-25 12:22
 

成都鈉鈳鋰生物科技有限公司

企業(yè)會(huì)員第5年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

nkl-00094
中文名稱:甘草素
中文別名:甘草醇;4′,7-二羥基黃烷酮(左旋) ;甘草黃酮配質(zhì)
英文名稱:Liquiritigenin
英文別名:(2S)-Liquiritigenin; 4′,7-Dihydroxyflavanone;
CAS號(hào):578-86-9
純度: HPLC≥98%

分子式:C15H12O4
分子量:256.25
外觀:無色長(zhǎng)針狀結(jié)晶
熔點(diǎn): 182-183 °C
沸點(diǎn): 529.5±50.0 °C | Condition
密度: 1.386±0.06 g/cm3 | Condition: Temp: 20 °C
pKa 值: 7.71±0.40 | Condition: Most Acidic Temp: 25 °C
提取來源:甘草
藥理藥效:解痙,抗?jié)儯咕?梢种茊伟费趸福瑥亩委熞钟粜跃癫?br /> 規(guī)格:10mg,20mg,50mg;可根據(jù)客戶需求包裝、定制

儲(chǔ)存條件: 低溫,避光、干燥、密封

用途: 用于鑒別、含量測(cè)定、藥理實(shí)驗(yàn)、活性篩選等科研、實(shí)驗(yàn)室使用;不得直接用于人體

供應(yīng)商:成都鈉鈳鋰生物科技有限公司

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
2”-O-沒食子酰基金絲桃苷 CAS:53209-27-1 甘草酸 CAS:1405-86-3 甘草酸銨 CAS:53956-04-0 甘草查爾酮A CAS:58749-22-7 甘草查爾酮B CAS:58749-23-8 甘草查爾酮C CAS:144506-14-9 重樓皂苷II CAS:50773-42-7 重樓皂苷III CAS:19057-60-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |